Drug Shortage Report for SODIUM NITROPRUSSIDE FOR INJECTION
Report ID | 141744 |
Drug Identification Number | 02479109 |
Brand name | SODIUM NITROPRUSSIDE FOR INJECTION |
Common or Proper name | Sodium Nitroprusside |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM NITROPRUSSIDE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 Vial |
ATC code | C02DD |
ATC description | ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-06-20 |
Actual start date | 2021-06-20 |
Estimated end date | 2022-01-31 |
Actual end date | 2022-01-07 |
Shortage status | Resolved |
Updated date | 2022-01-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-01-08 | French | Compare |
v5 | 2022-01-08 | English | Compare |
v4 | 2022-01-04 | French | Compare |
v3 | 2022-01-04 | English | Compare |
v2 | 2021-07-02 | French | Compare |
v1 | 2021-07-02 | English | Compare |
Showing 1 to 6 of 6